Păsărică Mihai Adrian, Curcă Paul Filip, Burcea Marian, Schmitzer Speranța, Dragosloveanu Christiana Diana Maria, Grigorescu Alexandru Călin
Clinical Department of Ophthalmology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Ophthalmology, Clinical Hospital for Ophthalmological Emergencies, 010464 Bucharest, Romania.
Diagnostics (Basel). 2023 May 29;13(11):1907. doi: 10.3390/diagnostics13111907.
(1) Background: Uveal malignant melanoma is the most common adult eye cancer and presents metabolic reprogramming that affects the tumoral microenvironment by altering the redox balance and producing oncometabolites. (2) Methods: The study prospectively evaluated patients undergoing enucleation surgery or stereotactic radiotherapy for uveal melanoma by following systemic oxidative-stress redox markers serum lipid peroxides, total albumin groups and total antioxidant levels (3) Results: Serum antioxidants and lipid peroxides were elevated from pre-treatment to longer-term follow-up. Antioxidants inversely correlated to lipid peroxides: higher in stereotactic radiosurgery patients pre/6/12/18 months post-treatment ( = 0.001-0.049) versus higher lipid peroxides in enucleation surgery patients pre/after/6 months post-treatment ( = 0.004-0.010). An increased variance in serum antioxidants was observed for enucleation surgery patients ( < 0.001), however enucleation did not increase mean serum antioxidants or albumin thiols; only lipid peroxides were increased post-enucleation ( < 0.001) and at 6-month follow-up ( = 0.029). Mean albumin thiols were increased for 18- and 24-month follow-ups ( = 0.017-0.022). Males who had enucleation surgery presented higher variance in serum determinations and overall higher lipid peroxides values pre/post-treatment and at the 18-month follow-up. (4) Conclusions: Initial oxidative stress-inducing events of surgical enucleation or stereotactic radiotherapy for uveal melanoma are followed by a longer-term inflammatory cascade gradually subsiding at later follow-ups.
(1) 背景:葡萄膜恶性黑色素瘤是最常见的成人眼癌,其呈现出代谢重编程,通过改变氧化还原平衡和产生致癌代谢物来影响肿瘤微环境。(2) 方法:本研究通过追踪全身氧化应激氧化还原标志物血清脂质过氧化物、总白蛋白组和总抗氧化水平,对接受眼球摘除手术或立体定向放射治疗的葡萄膜恶性黑色素瘤患者进行前瞻性评估。(3) 结果:从治疗前到长期随访,血清抗氧化剂和脂质过氧化物水平升高。抗氧化剂与脂质过氧化物呈负相关:立体定向放射外科手术患者在治疗前/治疗后6/12/18个月时抗氧化剂水平较高(P = 0.001 - 0.049),而眼球摘除手术患者在治疗前/治疗后/治疗后6个月时脂质过氧化物水平较高(P = 0.004 - 0.010)。观察到眼球摘除手术患者血清抗氧化剂的方差增加(P < 0.001),然而眼球摘除并未增加血清抗氧化剂或白蛋白巯基的平均值;仅在眼球摘除后(P < 0.001)和6个月随访时(P = 0.029)脂质过氧化物增加。在18个月和24个月随访时平均白蛋白巯基增加(P = 0.017 - 0.022)。接受眼球摘除手术的男性在血清测定中呈现出更高的方差,并且在治疗前/治疗后和18个月随访时总体脂质过氧化物值更高。(4) 结论:葡萄膜恶性黑色素瘤的手术摘除或立体定向放射治疗引发的初始氧化应激诱导事件之后,会出现长期的炎症级联反应,在后续随访中逐渐消退。